Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression (scientific article)

Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues

Q28264982

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

Q29620551

Expression of estrogen receptor alpha mRNA and protein variants in human endometrial carcinoma

Q30304102

Theories of endometrial carcinogenesis: a multidisciplinary approach

Q33886758

Cancer statistics, 2000.

Q33895772

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

Q35707414

Endometrial cancer and estrogen use. Report of a large case-control study

Q40185698

Estrogen receptor beta acts as a dominant regulator of estrogen signaling

Q40847288

Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation

Q40930380

Progesterone receptor A and B protein expression in human breast cancer

Q40971234

Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors

Q44599327

Estrogen enhances endometrial estrogen receptor gene expression by a posttranscriptional mechanism in the ovariectomized ewe.

Q48065771

Proliferative endometrial response to theca-granulosa cell tumors

Q68631935

Endometrial adenocarcinoma in stein-leventhal syndrome

Q69812605

Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas

Q70636245

The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens

Q73222352

Estrogen receptors alpha and beta form heterodimers on DNA

Q73555536

Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells

Q77932887

Estrogens and endometrial carcinoma

Q93496362

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

adenocarcinoma

Q356033

P304

page(s)

6965-6969

P577

publication date

2001-10-01

P1433

published in

Oncogene

Q1568657

P1476

title

Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression

P478

volume

Reverse relations

cites work (P2860)

Q37381777	Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology
Q37854068	Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers?
Q54530132	Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma.
Q30434843	Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation
Q33616773	Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
Q28249571	Estrogen receptor β: the guardian of the endometrium
Q43263578	Expression of estrogen and progesterone receptor genes in endometrium, myometrium and vagina of postmenopausal women treated with estriol.
Q53208025	Hormone Receptor Expression in Spontaneous Uterine Adenocarcinoma in Fischer 344 Rats.
Q42853689	Identification of novel transcript variants of estrogen receptor α, β and progesterone receptor gene in human endometrium.
Q92260315	Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells
Q36580666	Malignant mixed mullerian tumour, heterologous in a 66-year-old malay lady - a case report.
Q90021888	Meningiomas Display a Specific Immunoexpression Pattern in a Rostrocaudal Gradient: An Analysis of 366 Patients
Q37452832	Metastatic uterine adenocarcinoma in an 8-year-old gilt
Q39750078	Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component
Q34652138	Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis
Q64269902	Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma
Q92744508	Proteomic analysis of malignant and benign endometrium according to obesity and insulin-resistance status using Reverse Phase Protein Array
Q37903655	The different roles of ER subtypes in cancer biology and therapy
Q37178458	Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma